# Cluster4-10 Analysis

## Proteins: 

CCDC138, CCNC, CDK19, CDK8, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9, PDZK1

### Mediator Complex in Transcription Regulation

#### Summary

The human protein system analyzed in this report consists of 25 proteins, most of which are involved in the Mediator complex, a multi-protein complex that plays a crucial role in transcription regulation by RNA polymerase II. The majority of the proteins are localized in the nucleus and nucleoplasm and are involved in various aspects of transcription initiation, elongation, and regulation. The system also includes proteins with kinase and ubiquitin ligase activities, which may contribute to the regulation of transcription and other cellular processes. Based on the analysis, this system is not a novel complex, but rather a known complex with some novel members.

#### Cellular Components and Complexes

The proteins in this system are primarily involved in the Mediator complex, which is a key component of the transcription machinery in eukaryotic cells. The Mediator complex is composed of 22 proteins, including CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, and MED9. These proteins are localized in the nucleus and nucleoplasm, and are involved in various aspects of transcription regulation, such as initiation, elongation, and coregulation.

In addition to the Mediator complex, some proteins in this system are also involved in other cellular components and complexes, such as the ubiquitin ligase complex (MED12, MED17, MED27, MED30, and MED31), the transcription regulator complex (MED17, MED23, MED25, and MED27), and the plasma membrane (ILK and PDZK1).

#### Mechanisms and Biological Processes

The primary function of the Mediator complex is to regulate transcription by RNA polymerase II. This complex is involved in multiple steps of transcription, including initiation, elongation, and regulation. The proteins in this system are involved in various aspects of these processes, such as transcription coregulator activity (MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED29, MED30, MED31, MED4, and MED9) and transcription coactivator activity (MED1, MED12, MED13, MED14, MED17, MED21, MED23, MED27, MED30, MED4, and MED6).

Some proteins in this system also have kinase activity (CDK19, CDK8, and ILK) and ubiquitin ligase activity (MED12, MED17, MED27, MED30, and MED31), which may contribute to the regulation of transcription and other cellular processes. Other biological processes performed by this system include somatic stem cell population maintenance (MED12, MED14, MED15, MED17, MED21, MED27, MED28, MED30, and MED6) and cell cycle regulation (CDK19 and CDK8).

#### Proposed Name

Based on the cellular location and function of the proteins in this system, a suitable name for this system would be "Mediator Complex in Transcription Regulation". This name reflects the primary role of the Mediator complex in regulating transcription by RNA polymerase II and the involvement of the majority of the proteins in this system in this process.

#### References

1. Kornberg, R. D. (2005). Mediator and the mechanism of transcriptional activation. Trends in Biochemical Sciences, 30(5), 235-239. [DOI: 10.1016/j.tibs.2005.03.011](https://doi.org/10.1016/j.tibs.2005.03.011)

2. Malik, S., & Roeder, R. G. (2010). The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nature Reviews Genetics, 11(11), 761-772. [DOI: 10.1038/nrg2901](https://doi.org/10.1038/nrg2901)

3. Allen, B. L., & Taatjes, D. J. (2015). The Mediator complex: a central integrator of transcription. Nature Reviews Molecular Cell Biology, 16(3), 155-166. [DOI: 10.1038/nrm3951](https://doi.org/10.1038/nrm3951)

## Gene Feature Summary: 

| Feature | Number of Genes | Genes |
| --- | --- | --- |
| protein binding | 22 | CCNC, CDK8, ILK, MED1, MED12, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9, PDZK1 |
| nucleus | 22 | CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| mediator complex | 22 | CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| nucleoplasm | 19 | CCNC, CDK19, CDK8, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6 |
|  transcription initiation by RNA polymerase II | 19 | MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
|  transcription elongation by RNA polymerase II | 17 | MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| RNA polymerase II preinitiation complex assembly | 17 | MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
| core mediator complex | 17 | MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9 |
|  transcription by RNA polymerase II | 16 | CCNC, CDK8, MED1, MED12, MED13, MED14, MED17, MED18, MED21, MED23, MED25, MED27, MED29, MED31, MED4, MED6 |
| transcription coregulator activity | 14 | MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED29, MED30, MED31, MED4, MED9 |
| transcription coactivator activity | 11 | MED1, MED12, MED13, MED14, MED17, MED21, MED23, MED27, MED30, MED4, MED6 |
| membrane | 10 | ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED28, MED4, MED6 |
|  DNA-templated transcription | 9 | ILK, MED1, MED12, MED13, MED14, MED17, MED23, MED30, MED4 |
| somatic stem cell population maintenance | 9 | MED12, MED14, MED15, MED17, MED21, MED27, MED28, MED30, MED6 |
| nuclear receptor coactivator activity | 7 | MED1, MED12, MED13, MED14, MED17, MED30, MED4 |
| nuclear vitamin D receptor binding | 7 | MED1, MED12, MED13, MED14, MED17, MED30, MED4 |
| nuclear thyroid hormone receptor binding | 6 | MED1, MED12, MED13, MED17, MED30, MED4 |
| ubiquitin protein ligase activity | 5 | MED12, MED17, MED27, MED30, MED31 |
| protein ubiquitination | 5 | MED12, MED17, MED27, MED30, MED31 |
| ubiquitin ligase complex | 5 | MED12, MED17, MED27, MED30, MED31 |
| transcription regulator complex | 4 | MED17, MED23, MED25, MED27 |
| ATP binding | 3 | CDK19, CDK8, ILK |
| protein serine kinase activity | 3 | CDK19, CDK8, ILK |
| protein phosphorylation | 3 | CDK19, CDK8, ILK |
| cytosol | 3 | CDK19, ILK, MED27 |
| nucleolus | 3 | CDK8, MED1, MED27 |
| transcription coactivator binding | 3 | MED1, MED25, MED6 |
| transcription initiation at RNA polymerase II promoter | 3 | MED17, MED23, MED27 |
| G0 to G1 transition | 2 | CCNC, MED1 |
| cyclin-dependent protein serine/threonine kinase activity | 2 | CDK19, CDK8 |
|  cell cycle | 2 | CDK19, CDK8 |
| cell morphogenesis | 2 | ILK, MED1 |
| plasma membrane | 2 | ILK, PDZK1 |
| DNA binding | 2 | MED1, MED6 |
| chromatin binding | 2 | MED1, MED12 |
| nuclear retinoic acid receptor binding | 2 | MED1, MED25 |
| protein-containing complex binding | 2 | MED1, PDZK1 |
| negative regulation of transcription by RNA polymerase II | 2 | MED1, MED25 |
|  gene expression | 2 | MED1, MED23 |
| transcription factor binding | 2 | MED12, MED29 |
| DNA-templated transcription | 2 | MED12, MED13 |
| cytoplasm | 2 | MED15, MED22 |
| negative regulation of fibroblast proliferation | 2 | MED25, MED31 |

